Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiplexed genetic analysis using an expanded genetic alphabet.

Scott C Johnson1, David J Marshall, Gerda Harms

  • 1Eragen Biosciences, Inc., Madison, WI 53717, USA.

Clinical Chemistry
|August 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recognition of non-standard base pairs by triplex-forming oligonucleotides containing an expanded genetic alphabet.

Nature communications·2026
Same author

The Utility of Salivary 11-Dehydrodexamethasone as a Marker of Dexamethasone Absorption.

The Journal of clinical endocrinology and metabolism·2026
Same author

Ribose Accumulation in Borate-Rich Prebiotic Environments.

Astrobiology·2026
Same author

Viking Mars, Now 50 Years Old, Still Needs a Scientific Analysis.

Astrobiology·2025
Same author

Interstep compatibility of a model for the prebiotic synthesis of RNA consistent with Hadean natural history.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Draft genome and alcohol dehydrogenase dataset of thermoanaerobacter uzonensis bacterium strain AK85.

Data in brief·2025
Same journal

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

Clinical chemistry·2026
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
Same journal

Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

Clinical chemistry·2026
See all related articles

A new multiplex genetic testing platform accurately identifies mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This innovation could expand newborn screening capabilities for genetic diseases.

Area of Science:

  • Genetics
  • Molecular Biology
  • Biotechnology

Background:

  • Newborn screening policies vary significantly across states.
  • High costs and complexity of genetic tests limit newborn screening expansion.
  • Development of efficient genetic screening platforms is crucial.

Purpose of the Study:

  • To develop and technically evaluate a novel multiplex genetic testing platform.
  • To assess the platform's potential for increasing newborn genetic screening.
  • To test for mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Main Methods:

  • A three-step multiplex platform: PCR, target-specific extension, and liquid chip decoding.
  • Utilized an additional base pair for site-specific labeling and room-temperature decoding.

Related Experiment Videos

  • Tested 225 samples retrospectively and >400 newborns prospectively for CFTR gene mutations.

    • Main Results:

    • Retrospective study: 99.1% correct genotyping with no incorrect calls.
    • Prospective study: 95% correct genotyping for all targets, with no incorrect calls.
    • The platform demonstrated high accuracy in clinical sample testing.

    Conclusions:

    • A unique genetic multiplexing platform successfully tested 31 targets within the CFTR gene.
    • The platform provides accurate genotype assignments in a clinical setting.
    • This technology may facilitate broader implementation of newborn genetic screening.